dalteparin has been researched along with Cronobacter Infections in 1 studies
Dalteparin: A low-molecular-weight fragment of heparin, prepared by nitrous acid depolymerization of porcine mucosal heparin. The mean molecular weight is 4000-6000 daltons. It is used therapeutically as an antithrombotic agent. (From Merck Index, 11th ed)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Amezyane, T | 1 |
| Abouzahir, A | 1 |
| El Kharrass, A | 1 |
| Bassou, D | 1 |
| Fatihi, J | 1 |
| Hammi, S | 1 |
| Mahassin, F | 1 |
| Ghafir, D | 1 |
| Ohayon, V | 1 |
1 other study available for dalteparin and Cronobacter Infections
| Article | Year |
|---|---|
[Septic pylephlebitis associated with Enterobacter cloacae septicemia].
Topics: Abdominal Pain; Adult; Anti-Bacterial Agents; Anticoagulants; Bacteremia; Ceftriaxone; Community-Acq | 2010 |